“中国肠道微生态与疾病转化联盟”邀请您加入

2017-12-29 MedSci MedSci原创

           小编推荐:您不可错过的2018(第四届)肠道微生态与健康国际研讨会 近年来不断有研究发现人体内微生物与许多疾病的发生密切相关,如炎症、肿瘤、神经退行性疾病、肥胖、抑郁等。然而超过70%的肠道微生物却无法用传统方法分离和培养,这极大地限制了科学家对微生物的了解,宏基因组测序技术的发展让研究人员能够研究肠道内的

           小编推荐:您不可错过的2018(第四届)肠道微生态与健康国际研讨会
 
近年来不断有研究发现人体内微生物与许多疾病的发生密切相关,如炎症、肿瘤、神经退行性疾病、肥胖、抑郁等。然而超过70%的肠道微生物却无法用传统方法分离和培养,这极大地限制了科学家对微生物的了解,宏基因组测序技术的发展让研究人员能够研究肠道内的“微生物暗物质”;类肠器官构建则使科学家能更好地模拟体内肠环境,进而揭示复杂的生态机制。基于此,目前对于人体内微生物尤其是肠道微生物的研究如雨后春笋般出现,研究人员希望通过研究人类肠道中的微生物群落,了解人肠道中细菌的物种分布以及与人体互作的关系,最终为研究肠道微生物与疾病的发生机制,以及如何调节人体健康提供非常重要的理论依据。
 
结合《“健康中国2030”规划纲要》,《“十三五”国家科技创新规划》,推动健康科技创新,建立创新协同体系,推广创新成果,促进发展。 我们倡议国内微生态相关机构联合成立“中国肠道微生态与疾病转化联盟”,英文名为 China Union of Gut Microecology and Disease(CUMD)。通过联盟“合作攻关,顶层设计”推进肠道微生态临床研究与成果推广。

联盟联合若干在肠道中国肠道微生态与疾病转化联盟领域科技成果卓越的高校科研院所、生物技术公司,医药企业,医疗机构等,自愿组建专注于肠道微生态集成创新、长效稳定的合作组织。联盟以共同的发展需求为基础、以创新机制突破重大微生态临床研究项目为目标。

中国肠道微生态与疾病转化联盟的宗旨:遵守宪法、法律、法规和国家政策;遵守社会道德风尚;围绕我国所面临重大疾病、难治性疾病和微生态创新的关键问题,联合领域的机构,开展技术分工合作,突破发展的核心技术,形成技术标准,建立公共技术平台,实现创新资源的有效分工与合理衔接,提升微生态临床整体竞争力。中国肠道微生态与疾病转化联盟积极开展国际国内合作,联合培养人才,加强人员的交流互动,促进我国微生态研究与临床转化的健康发展。

欢迎国内外的医疗机构,专业企业及相关大学、科研院校、企业等申请加入本联盟。单位或个人提交申请书至秘书处,秘书处审查核实材料的正式性,并提交至联盟理事会(筹委会代)评定资质,经获批准后,即成为联盟的正式成员,并享有相关权益,如:信息发布、项目合作对接、科研服务等。

“2018(第四届)肠道微生态与健康国际研讨会”,将于2018年3月30日-31日在上海召开。联盟兹定于3月30日在上海举行成立仪式及召开首届成员会议,期间理事会颁发联盟成员证书及联盟材料集。


 联盟申请书下载链接地址:http://www.bioon.com/z/download1226/cd.doc
 填写后发送到邮箱:shengnan.zhang@bioon.com 联系人:张胜楠   15018473667


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=275945, encodeId=4b022e5945dc, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sat Jan 06 09:20:27 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275417, encodeId=4cc12e541766, content=学习谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Thu Jan 04 14:42:50 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496619, encodeId=8c18149661954, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Dec 31 05:36:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273802, encodeId=b18e2e3802ed, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sat Dec 30 09:28:16 CST 2017, time=2017-12-30, status=1, ipAttribution=)]
    2018-01-06 大爰

    学习了谢谢分享!!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=275945, encodeId=4b022e5945dc, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sat Jan 06 09:20:27 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275417, encodeId=4cc12e541766, content=学习谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Thu Jan 04 14:42:50 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496619, encodeId=8c18149661954, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Dec 31 05:36:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273802, encodeId=b18e2e3802ed, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sat Dec 30 09:28:16 CST 2017, time=2017-12-30, status=1, ipAttribution=)]
    2018-01-04 lou.minghong

    学习谢谢分享!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=275945, encodeId=4b022e5945dc, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sat Jan 06 09:20:27 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275417, encodeId=4cc12e541766, content=学习谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Thu Jan 04 14:42:50 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496619, encodeId=8c18149661954, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Dec 31 05:36:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273802, encodeId=b18e2e3802ed, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sat Dec 30 09:28:16 CST 2017, time=2017-12-30, status=1, ipAttribution=)]
    2017-12-31 docwu2019
  4. [GetPortalCommentsPageByObjectIdResponse(id=275945, encodeId=4b022e5945dc, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sat Jan 06 09:20:27 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275417, encodeId=4cc12e541766, content=学习谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Thu Jan 04 14:42:50 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496619, encodeId=8c18149661954, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Dec 31 05:36:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273802, encodeId=b18e2e3802ed, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sat Dec 30 09:28:16 CST 2017, time=2017-12-30, status=1, ipAttribution=)]
    2017-12-30 大爰

    学习了谢谢分享!!

    0

相关资讯

2018(第四届)肠道微生态与健康国际研讨会2

人体内的肠道微生物数量大约100万亿个,超过自身细胞总量的10倍以上,是人体的“第二基因组”。近年来不断有研究发现人体内微生物与许多疾病的发生密切相关,如炎症、肿瘤、神经退行性疾病、肥胖、抑郁等。然而超过70%的肠道微生物却无法用传统方法分离和培养,这极大地限制了科学家对微生物的了解。

2018(第四届)肠道微生态与健康国际研讨会蓄势待发,6大亮点吸引了1000人

  导读:2018(第四届)肠道微生态与健康国际研讨会已经可以开始报名啦,看完这6大精彩亮点,您还不心动吗?2018-03-30至2018-03-31,我们上海见! 用传统方法无法对肠道微生物进行分离和培养,对微生物的了解又如何进行?目前就肠道微生物的研究如雨后春笋,又该如何研究?继2015年后,生物谷已经成功举办了三届肠道微生态与健康研讨会,参会人员达***!2018